Home » Topics » BioWorld Science

BioWorld Science
RSS

IDP Discovery Pharma describes new VEGF inhibitors

July 28, 2022

Jiangsu Chia Tai Tianqing Pharmaceutical Group patents G12C mutant GTPase KRAS inhibitors

July 28, 2022

New galectin-3 inhibitors synthesized at Galecto Biotech

July 28, 2022

Shionogi discovers 5-HT2A receptor antagonists and/or inverse agonists

July 28, 2022

Medshine Discovery identifies new CREBBP and/or p300 inhibitors

July 28, 2022

ZyVersa receives grant to assess potential of IC-100 to block neuroinflammation in Parkinson's

July 27, 2022

Vitamin B6 benzohydrazide platinum(II) complexes overcome cisplatin resistance in tumors

July 27, 2022

Amubarvimab/romlusevimab retains neutralizing activity against live Omicron subvariants

July 27, 2022

Monoclonal antibody pairs "zipper" to target cancer

July 27, 2022

New MAT2A inhibitors discovered at Jiangsu Simcere Pharmaceutical R&D

July 27, 2022

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 31, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 31, 2025.
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...
IMV-101 shows promise for B-cell malignancies
BioWorld Science
IMV-101 is a new CAR T-cell therapy targeting CD19 developed by Suzhou Immunofoco Biotechnology Co. Ltd. for the potential treatment of B-cell malignancies and...